Nicklas Westerholm

All filings by Nicklas Westerholm on record concern Egetis Therapeutics AB (publ). Over a trading history stretching from 11 May 2026 to 31 August 2026, the count stands at 4 filings.

In open-market terms, that means 3 purchases on one side and 1 sale worth €170k on the other. The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 3 September 2026 came the latest disclosure, an open-market purchase in Egetis Therapeutics AB (publ). The median gap between a trade and its publication by Finansinspektionen is 4 days. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.